PLEASANTON, Calif., Dec. 21, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that it
will hold its next annual meeting of stockholders on Monday, March 13, 2017. Stockholders of record as of the close of
business on January 17, 2017 will be eligible to vote on matters presented in the Company's proxy statement, including electing its
slate of directors.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is
dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business
units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing
a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is
committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health,
fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100
countries. For more information, please visit www.coopercos.com
COO-G
CONTACT: Kim Duncan Vice President, Investor Relations ir@cooperco.com
